{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/PCSA/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T16:15:09.482Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":12351,"canonical_name":"Processa Pharmaceuticals, Inc.","cik":"0001533743","uei":null,"lei":null,"duns":null,"ticker":"PCSA"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":63},"count":63,"timeline":[{"ts":"2026-10-09","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Processa Pharmaceuticals, Inc. — 2026-10-09","url_slug":"/sec/cik-0001533743/pre-14a/0001140361-26-039267","accession_number":"0001140361-26-039267","importance":30},{"ts":"2026-10-09","kind":"sec.filing","form_type":"PRE 14A","title":"PRE 14A — Processa Pharmaceuticals, Inc. — 2026-10-09","url_slug":"/sec/cik-0001533743/pre-14a/0001140361-26-039268","accession_number":"0001140361-26-039268","importance":30},{"ts":"2026-10-09","kind":"sec.filing","form_type":"S-3","title":"S-3 — Processa Pharmaceuticals, Inc. — 2026-10-09","url_slug":"/sec/cik-0001533743/s-3/0001140361-26-039266","accession_number":"0001140361-26-039266","importance":30},{"ts":"2026-10-05","kind":"sec.filing","form_type":"8-K/A","title":"8-K/A — Processa Pharmaceuticals, Inc. — 2026-10-05","url_slug":"/sec/cik-0001533743/8-k-a/0001140361-26-038535","accession_number":"0001140361-26-038535","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Processa Pharmaceuticals, Inc. — 2026-08-18","url_slug":"/sec/cik-0001533743/schedule-13g/0001213900-26-091285","accession_number":"0001213900-26-091285","importance":55},{"ts":"2026-08-14","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Processa Pharmaceuticals, Inc. — 2026-08-14","url_slug":"/sec/cik-0001533743/10-q/0001493152-26-038334","accession_number":"0001493152-26-038334","importance":45},{"ts":"2026-08-11","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-08-11","url_slug":"/sec/cik-0001533743/4/0000897069-26-001602","accession_number":"0000897069-26-001602","importance":30},{"ts":"2026-08-08","kind":"sec.insider.m","reporter":"Ng George K","title":"Chief Executive Officer","shares":1600,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-08-04","kind":"sec.filing","form_type":"8-K","title":"8-K — Processa Pharmaceuticals, Inc. — 2026-08-04","url_slug":"/sec/cik-0001533743/8-k/0001493152-26-036032","accession_number":"0001493152-26-036032","importance":35},{"ts":"2026-07-30","kind":"sec.filing","form_type":"3","title":"3 — Processa Pharmaceuticals, Inc. — 2026-07-30","url_slug":"/sec/cik-0001533743/3/0001575202-26-000009","accession_number":"0001575202-26-000009","importance":30},{"ts":"2026-07-30","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-30","url_slug":"/sec/cik-0001533743/4/0001575202-26-000011","accession_number":"0001575202-26-000011","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"8-K","title":"8-K — Processa Pharmaceuticals, Inc. — 2026-07-29","url_slug":"/sec/cik-0001533743/8-k/0001493152-26-035099","accession_number":"0001493152-26-035099","importance":35},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-28","url_slug":"/sec/cik-0001533743/4/0000897069-26-001546","accession_number":"0000897069-26-001546","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-28","url_slug":"/sec/cik-0001533743/4/0000897069-26-001548","accession_number":"0000897069-26-001548","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-28","url_slug":"/sec/cik-0001533743/4/0000897069-26-001550","accession_number":"0000897069-26-001550","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-28","url_slug":"/sec/cik-0001533743/4/0000897069-26-001552","accession_number":"0000897069-26-001552","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-28","url_slug":"/sec/cik-0001533743/4/0000897069-26-001554","accession_number":"0000897069-26-001554","importance":30},{"ts":"2026-07-28","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-28","url_slug":"/sec/cik-0001533743/4/0000897069-26-001556","accession_number":"0000897069-26-001556","importance":30},{"ts":"2026-07-01","kind":"sec.insider.p","reporter":"Ng George K","title":"Chief Executive Officer","shares":3057,"price_per_share":1.93,"usd_value":5900,"security_title":"Common Stock","importance":50.00590001},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-01","url_slug":"/sec/cik-0001533743/4/0000897069-26-001480","accession_number":"0000897069-26-001480","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-01","url_slug":"/sec/cik-0001533743/4/0000897069-26-001482","accession_number":"0000897069-26-001482","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-07-01","url_slug":"/sec/cik-0001533743/4/0000897069-26-001484","accession_number":"0000897069-26-001484","importance":30},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"SKIBSTED RUSSELL","title":"Chief Financial Officer","shares":3277,"price_per_share":1.93,"usd_value":6325,"security_title":"Common Stock","importance":50.00632461},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"Young David","title":"Pres. Research & Development","shares":2531,"price_per_share":1.93,"usd_value":4885,"security_title":"Common Stock","importance":50.00488483},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"Guy Wendy","title":"Chief Administrative Officer","shares":2436,"price_per_share":1.93,"usd_value":4701,"security_title":"Common Stock","importance":50.00470148},{"ts":"2026-06-30","kind":"sec.insider.p","reporter":"Lin Patrick","title":"Chief Business - Strategy Off","shares":2106,"price_per_share":1.93,"usd_value":4065,"security_title":"Common Stock","importance":50.00406458},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Yorke Justin W — 2026-06-30","url_slug":"/sec/cik-0001361896/4/0000897069-26-001472","accession_number":"0000897069-26-001472","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-30","url_slug":"/sec/cik-0001533743/4/0000897069-26-001466","accession_number":"0000897069-26-001466","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-30","url_slug":"/sec/cik-0001533743/4/0000897069-26-001468","accession_number":"0000897069-26-001468","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-30","url_slug":"/sec/cik-0001533743/4/0000897069-26-001470","accession_number":"0000897069-26-001470","importance":30},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Yorke Justin W","title":null,"shares":203,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Baluch Khoso","title":null,"shares":203,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Pannu Geraldine","title":null,"shares":203,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Neal James R","title":null,"shares":203,"price_per_share":null,"usd_value":0,"security_title":"Common Stock","importance":15},{"ts":"2026-06-18","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Processa Pharmaceuticals, Inc. — 2026-06-18","url_slug":"/sec/cik-0001533743/def-14a/0001493152-26-029326","accession_number":"0001493152-26-029326","importance":40},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-16","url_slug":"/sec/cik-0001533743/4/0000897069-26-001406","accession_number":"0000897069-26-001406","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-16","url_slug":"/sec/cik-0001533743/4/0000897069-26-001408","accession_number":"0000897069-26-001408","importance":30},{"ts":"2026-06-16","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-16","url_slug":"/sec/cik-0001533743/4/0000897069-26-001410","accession_number":"0000897069-26-001410","importance":30},{"ts":"2026-06-15","kind":"sec.insider.p","reporter":"SKIBSTED RUSSELL","title":"Chief Financial Officer","shares":2654,"price_per_share":2.22,"usd_value":5892,"security_title":"Common Stock","importance":50.00589188},{"ts":"2026-06-15","kind":"sec.insider.p","reporter":"Ng George K","title":"Chief Executive Officer","shares":2465,"price_per_share":2.22,"usd_value":5472,"security_title":"Common Stock","importance":50.0054723},{"ts":"2026-06-15","kind":"sec.insider.p","reporter":"Guy Wendy","title":"Chief Administrative Officer","shares":2118,"price_per_share":2.22,"usd_value":4702,"security_title":"Common Stock","importance":50.00470196},{"ts":"2026-06-15","kind":"sec.insider.p","reporter":"Young David","title":"Pres. Research & Development","shares":2067,"price_per_share":2.22,"usd_value":4589,"security_title":"Common Stock","importance":50.00458874},{"ts":"2026-06-15","kind":"sec.insider.p","reporter":"Lin Patrick","title":"Chief Business - Strategy Off","shares":1831,"price_per_share":2.22,"usd_value":4065,"security_title":"Common Stock","importance":50.00406482},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-01","url_slug":"/sec/cik-0001533743/4/0000897069-26-001287","accession_number":"0000897069-26-001287","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-01","url_slug":"/sec/cik-0001533743/4/0000897069-26-001289","accession_number":"0000897069-26-001289","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-06-01","url_slug":"/sec/cik-0001533743/4/0000897069-26-001291","accession_number":"0000897069-26-001291","importance":30},{"ts":"2026-05-29","kind":"sec.insider.p","reporter":"SKIBSTED RUSSELL","title":"Chief Financial Officer","shares":2292,"price_per_share":2.57,"usd_value":5890,"security_title":"Common Stock","importance":50.00589044},{"ts":"2026-05-29","kind":"sec.insider.p","reporter":"Ng George K","title":"Chief Executive Officer","shares":2129,"price_per_share":2.57,"usd_value":5472,"security_title":"Common Stock","importance":50.00547153},{"ts":"2026-05-29","kind":"sec.insider.p","reporter":"Guy Wendy","title":"Chief Administrative Officer","shares":1829,"price_per_share":2.57,"usd_value":4701,"security_title":"Common Stock","importance":50.00470053},{"ts":"2026-05-29","kind":"sec.insider.p","reporter":"Young David","title":"Pres. Research & Development","shares":1786,"price_per_share":2.57,"usd_value":4590,"security_title":"Common Stock","importance":50.00459002},{"ts":"2026-05-29","kind":"sec.insider.p","reporter":"Lin Patrick","title":"Chief Business - Strategy Off","shares":1582,"price_per_share":2.57,"usd_value":4066,"security_title":"Common Stock","importance":50.00406574},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-05-19","url_slug":"/sec/cik-0001533743/4/0000897069-26-001176","accession_number":"0000897069-26-001176","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-05-19","url_slug":"/sec/cik-0001533743/4/0000897069-26-001182","accession_number":"0000897069-26-001182","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — Processa Pharmaceuticals, Inc. — 2026-05-19","url_slug":"/sec/cik-0001533743/4/0000897069-26-001186","accession_number":"0000897069-26-001186","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4/A","title":"4/A — Processa Pharmaceuticals, Inc. — 2026-05-19","url_slug":"/sec/cik-0001533743/4-a/0000897069-26-001154","accession_number":"0000897069-26-001154","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4/A","title":"4/A — Processa Pharmaceuticals, Inc. — 2026-05-19","url_slug":"/sec/cik-0001533743/4-a/0000897069-26-001167","accession_number":"0000897069-26-001167","importance":30},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"SKIBSTED RUSSELL","title":"Chief Financial Officer","shares":1984,"price_per_share":2.97,"usd_value":5892,"security_title":"Common Stock","importance":50.00589248},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"Ng George K","title":"Chief Executive Officer","shares":1843,"price_per_share":2.97,"usd_value":5474,"security_title":"Common Stock","importance":50.00547371},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"Guy Wendy","title":"Chief Administrative Officer","shares":1583,"price_per_share":2.97,"usd_value":4702,"security_title":"Common Stock","importance":50.00470151},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"Young David","title":"Pres. Research & Development","shares":1545,"price_per_share":2.97,"usd_value":4589,"security_title":"Common Stock","importance":50.00458865},{"ts":"2026-05-15","kind":"sec.insider.p","reporter":"Lin Patrick","title":"Chief Business - Strategy Off","shares":1369,"price_per_share":2.97,"usd_value":4066,"security_title":"Common Stock","importance":50.00406593},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Processa Pharmaceuticals, Inc. — 2026-05-15","url_slug":"/sec/cik-0001533743/schedule-13g-a/0001649553-26-000056","accession_number":"0001649553-26-000056","importance":30},{"ts":"2026-04-30","kind":"sec.insider.p","reporter":"Bigora Sian","title":"Chief Development Officer","shares":1971,"price_per_share":2.71,"usd_value":5341,"security_title":"Common Stock","importance":50.00534141}]}